Dexcom | DXCM - Equity Capital And Reserves

Stock Price
63.11
Daily Change
-0.10 -0.16%
Monthly
-8.19%
Yearly
3.99%
Q2 Forecast
60.35

Dexcom reported $2.75B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Align Technology USD 3.96B 44.68M Sep/2025
AtriCure USD 491.94M 15.43M Dec/2025
Avanos Medical USD 778.2M 200K Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Boston Scientific USD 24.23B 1.58B Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
Dexcom USD 2.75B 19.9M Dec/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
J&J USD 78.47B 0 Sep/2025
Masimo USD 721.2M 88.8M Dec/2025
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.58B 54.9M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Solventum Corp USD 5.05B 63M Dec/2025
Stryker USD 21.78B 594M Sep/2025
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
West Pharmaceutical Services USD 3.18B 124.5M Dec/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025